Yang 2021.
Study characteristics | |||
Patient Sampling | Cross‐sectional, observational study that recruited participants at the Casey Eye Institute at Oregon Health and Science University (OHSU), Portland, Oregon. Age‐matched normal participants were recruited from volunteers and people seeking refractive surgery consultation. All participants were aged 18 years or older. | ||
Patient characteristics and setting | A clinical diagnosis of keratoconus was established using a combination of corrected distance visual acuity (CDVA), slit‐lamp physical findings, topographic patterns, and the quantitative topography KISA%. Each keratoconic eye was assigned to 1 of the 3 keratoconic subgroups according to following classification scheme.
Age‐matched normal participants were recruited from volunteers and people seeking refractive surgery consultation. All normal eyes had CDVA ≥ 20/20, no signs of keratoconus on slit‐lamp examination, regular axial power map topography pattern (round, oval, symmetric bowtie, etc.), KISA% < 100%, and no ocular pathology other than myopia or hyperopia. Exclusion criteria: previous corneal surgeries, recent contact lens usage (soft contact lens within 1 week or rigid gas‐permeable lens within 3 weeks), inability to give informed consent, or inability to maintain stable fixation for imaging. Severe keratoconus with corneal scarring has unpredictable corneal and epithelial thickness patterns and does not pose a challenge for clinical diagnosis. |
||
Index tests | A 2‐step decision tree. Step 1 uses quantitative OCT pachymetric and epithelial thickness map parameters. If any of the 4 parameters listed in the previous section exceeds the cut‐off, the eye is suspicious for keratoconus and proceeds to step 2. If none of the 4 parameters exceeds the cut‐off, then the eye is considered normal and does not require step 2 examination. Step 2 requires a human grader to visually inspect the corneal and epithelial thickness maps and search for characteristic keratoconic map patterns of coincident thinning and concentric epithelial thinning. | ||
Target condition and reference standard(s) | Unclear who made the diagnosis. All cases were diagnosed before the analysis with the 2‐step decision tree. |
||
Flow and timing | Unclear if all cases were diagnosed by the same cornea specialists. All cases were included in the analysis. | ||
Comparative | Not applicable | ||
Notes | Supported by the National Institutes of Health, Bethesda, Maryland, USA (R01EY028755, R01EY029023, T32EY023211, and P30EY010572; E. Pavlatos, D. Huang, and Y. Li); a research grant and equipment support from OptoVue, Inc., Fremont, California (D. Huang and Y. Li); unrestricted grants to Casey Eye Institute from Research to Prevent Blindness, Inc., New York, New York (E. Pavlatos, W. Chamberlain, D. Huang, and Y. Li); National Natural Science Foundation of China, Beijing, China (81900830; Y. Yang). The sponsors did not participate in the data collection, data management, or data analysis in the study. | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient selection | |||
Was a consecutive or random sample of patients enrolled? | No | ||
Was a case‐control design avoided? | No | ||
Did the study avoid inappropriate exclusions? | No | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | High | ||
DOMAIN 2: Index test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | Unclear | ||
Was the model designed in an appropriate manner? | Yes | ||
Could the conduct or interpretation of the index test have introduced bias? | Low risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference standard | |||
Is the reference standard likely to correctly classify the target condition? | Unclear | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Yes | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Unclear risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and timing | |||
Did all patients receive the same reference standard? | Unclear | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk | ||
DOMAIN 5: Comparative |